India, July 28 -- Incyte Corp. (INCY) on Tuesday reported an increase in second-quarter earnings and revenue, driven by strong growth across its commercial portfolio. The company also raised its full-year 2026 sales guidance.
Second-quarter net income increased to $585.6 million or $2.81 per share, from $405.0 million or $2.04 per share a year earlier. Adjusted net income rose to $643.4 million or $3.09 per share from $311.9 million or $1.57 per share last year.
Total revenue grew 38% to $1.67 billion from $1.22 billion in the prior-year quarter. Total net sales increased 40% to $1.49 billion, benefiting from continued demand for marketed products and a one-time, non-cash $246 million benefit related to Opzelura following a CMS agreement....